Burning Rock Biotech Ltd. (BNR)
| Market Cap | 332.39M |
| Revenue (ttm) | 79.35M |
| Net Income (ttm) | -124.48M |
| Shares Out | 105.19M |
| EPS (ttm) | -1.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 834,423 |
| Open | 3.28 |
| Previous Close | 3.32 |
| Day's Range | 3.14 - 3.42 |
| 52-Week Range | 3.14 - 38.64 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 13.59 (+330.1%) |
| Earnings Date | May 24, 2022 |
About BNR
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. The company primarily offers 12 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoScreen IO, a pan-cancer test for ...
Financial Performance
In 2021, BNR's revenue was 507.86 million, an increase of 18.13% compared to the previous year's 429.90 million. Losses were -796.70 million, 95.6% more than in 2020.
Financial numbers in millions CNYFinancial StatementsAnalyst Forecast
According to 8 analysts, the average rating for BNR stock is "Buy." The 12-month stock price forecast is 13.59, which is an increase of 330.06% from the latest price.
News
Burning Rock Schedules First Quarter of 2022 Earnings Release on May 31, 2022
GUANGZHOU, China, May 16, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) t...
Cathie Wood Can't Get Enough of These 2 Biotech Stocks
The CEO of Ark Invest hasn't given up on these risky biotech stocks.
Tesla Bull Cathie Wood Bought $1M Shares In This Biotech Stock Today
Tesla Inc (NASDAQ: TSLA) bull Cathie Wood led Ark Investment Management on Thursday further raised its exposure in China-based biotech company Burning Rock Biotech Ltd (NASDAQ: BNR). The investment firm...
Burning Rock Reports Fourth Quarter and Full Year 2021 Financial Results
GUANGZHOU, China, March 21, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS)...
Burning Rock Secures Second NGS Kit Approval from the NMPA
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that the National Medical Products Administration (NMPA) ...
Burning Rock to Release MRD Clinical Data on NSCLC and CRC at the Upcoming American Association for Cancer Research A...
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it will present MRD (molecular residual disease) cli...
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022
GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) ...
Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 Million
GUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the Company ex...
Burning Rock Announces Results of 2021 Annual General Meeting
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) ...
Following Rough Year, Is Burning Rock Set To Turn The Corner?
Key Takeaways: Burning Rock expects fourth-quarter revenue to grow just 6% year-on-year due to latest Covid-related travel restrictions in China
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Burning Rock...
GUANGZHOU, China, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Merck KGaA, Darmstadt, German...
ARK Genomic Revolution fund starts position in Burning Rock Biotech
The ARK Genomic Revolution ETF ARKG, +2.01% started a position in Burning Rock Biotech BNR, +10.69% , a Chinese cancer sequencing technology company that jumped 11% after reporting third-quarter results...
Recap: Burning Rock Biotech Q3 Earnings
Burning Rock Biotech (NASDAQ:BNR) reported its Q3 earnings results on Tuesday, November 16, 2021 at 08:00 AM. Here's what investors need to know about the announcement.
Burning Rock Announces 2021 Annual General Meeting to be Held on December 28, 2021
GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS)...
Burning Rock Reports Third Quarter 2021 Financial Results
GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) ...
Burning Rock Collaborates with IMPACT Therapeutics to Provide Testing Services in Developing IMP9064 in both US and C...
GUANGZHOU, China, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a collaboration with IMPACT Therapeutics where Burning Roc...
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021
GUANGZHOU, China, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company foused on the application of next generation sequencing (NGS) t...
Burning Rock Reports Second Quarter 2021 Financial Results
GUANGZHOU, China, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) ...
Burning Rock and IMPACT Therapeutics Announce a Global Strategic Partnership for Companion Diagnostics Development
GUANGZHOU, China, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a global strategic partnership with IMPACT Therapeutics in...
Burning Rock Schedules Second Quarter of 2021 Earnings Release on August 31, 2021
GUANGZHOU, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) ...
New Strong Sell Stocks for June 24th
RAD, WTRH, BNR, NMR, and VNCE have been added to the Zacks Rank #5 (Strong Sell) List on June 24, 2021
New Strong Sell Stocks for June 11th
BLIN, BNR, MOV, BAP and SBRA have been added to the Zacks Rank #5 (Strong Sell) List on June 11, 2021.
New Strong Sell Stocks for June 3rd
ADSK, BNR, NET, ELMD, and POLY have been added to the Zacks Rank #5 (Strong Sell) List on June 3, 2021
Burning Rock Reports First Quarter 2021 Financial Results
GUANGZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) t...
Burning Rock Announces the Launch of China's First Prospective Pan-Cancer Multi-omics Early Detection Study
BEIJING, May 19, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced the launch of the PRESCIENT (Pan-canceR Early-Stage deteCtion by lIq...